[Changes of serum aminotransferase in children with obstructive sleep apnea hypopnea syndrome]

Zhenjiang Chen1, Likun Duo2

  • 1Department of Pediatrics, the Affiliated Jinxiang Hospital of Jining Medical College, Jining, 272200, China.

Insights

Obstructive sleep apnea hypopnea syndrome (OSAHS) may independently increase the risk of liver injury in children, even after accounting for obesity. Obese children with OSAHS show higher liver enzyme levels, indicating potential liver damage.

Area of Science:

  • Pediatric Gastroenterology
  • Sleep Medicine
  • Hepatology

Context:

  • Non-alcoholic fatty liver disease (NAFLD) and obstructive sleep apnea hypopnea syndrome (OSAHS) are prevalent conditions often linked to childhood obesity.
  • The independent contribution of OSAHS to liver injury, separate from obesity, remains unclear.

Purpose:

  • To investigate whether obstructive sleep apnea hypopnea syndrome (OSAHS) is an independent risk factor for liver injury in children.
  • To assess the association between OSAHS and elevated liver enzymes, considering obesity as a confounding factor.

Summary:

  • A study involving 130 children with OSAHS and 77 with primary snoring (PS) measured polysomnography, BMI, liver function, lipids, glucose, and insulin.
  • Children with OSAHS exhibited significantly higher rates of elevated serum aminotransferase levels compared to controls (P < 0.05).
  • Obese children also showed elevated aminotransferase levels more frequently than non-obese children (P < 0.05), with 93.3% of obese children with elevated enzymes having OSAHS.

Impact:

  • Findings suggest OSAHS may be an independent risk factor for liver injury in children.
  • Increased liver enzyme levels are common in obese children with snoring, particularly those diagnosed with OSAHS.
  • This highlights the importance of screening for OSAHS in obese children with potential liver issues.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
914
Alterations in Respiration II01:30

Alterations in Respiration II

There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632